Fujino Y, Fujimaki E, Orii S, Chiba S, Nakano O, Yamashiki H, Sato K, Sato S, Sasaki K
First Dept. of Internal Medicine, Iwate Medical University, School of Medicine.
Gan To Kagaku Ryoho. 1994 May;21 Suppl 1:72-4.
We evaluated the DNA ploidy in 23 lesions of colorectal carcinoma in adenoma (CIA) and 90 adenomas without carcinomas by flow cytometry using fresh samples. DNA ploidy of carcinoma and adenoma components were assessed, respectively, with 17 paraffin-embedded samples of CIAs. The incidence of DNA aneuploidy (AP) was significantly higher in CIAs than in adenomas (47.8% vs. 12.2%, p < 0.01). Even in adenoma components of CIAs, AP tended to be found more frequent than in adenomas (41.2% vs. 12.2%). The incidence of AP in adenoma components was similar to that in carcinoma components (35.3%) in CIAs. In conclusion, DNA aneuploidy in adenomas may be a marker of malignant potential.
我们使用新鲜样本通过流式细胞术评估了23例腺瘤性结直肠癌(CIA)病变和90例无癌腺瘤的DNA倍体。分别用17例CIA的石蜡包埋样本评估癌和腺瘤成分的DNA倍体。CIA中DNA非整倍体(AP)的发生率显著高于腺瘤(47.8%对12.2%,p<0.01)。即使在CIA的腺瘤成分中,AP的发现频率也往往高于腺瘤(41.2%对12.2%)。CIA中腺瘤成分的AP发生率与癌成分的发生率相似(35.3%)。总之,腺瘤中的DNA非整倍体可能是恶性潜能的标志物。